Navigation Links
First Genetic Cure For Cancer Anchors Provocative New Thriller

Dallas, TX (PRWEB) June 27, 2012

What would happen if a groundbreaking advance in medicine fell into the hands of a desperate Wall Street executive, hell-bent on taking the company public and turning a huge profit… no matter the cost.

In his newest novel, "Genetic Imperfections", author Steve Hadden deftly guides readers through the high-stakes world of pharmaceutical development while telling the story of a father turned bitter over the loss of his young son to cancer. Rexen Labs is sitting on a gold mine. After years of development, the family-owned pharmaceutical company is finally prepared to begin marketing the biggest drug breakthrough since penicillin, a genetic cure for cancer. With Rexen Labs ready to go public, billions of dollars—and a ten-year-old’s life—hang in the balance.

Asked why he wrote "Genetic Imperfections", Hadden said, “I’m intrigued by how the complexity of the human genome stands in the way of the first genetic cure for cancer and how corporate greed can transform the most well intended people.”

The thriller opens fifteen years ago, after David Wellington abandoned his lucrative banking career and joined Rexsen Labs to save his young son's life. But despite his sacrifices and prayers, he helplessly watches him die. On that day his heart hardens and he embarks on a path of cynicism, materialism and self-indulgence. Now, propelled by the pending FDA approval of CGT, the first genetic cure for the leukemia that killed his son, he's on the verge of becoming Newport Beach's newest billionaire.

But as Wellington watches his life crumble around him and the cure become a curse, he finds himself at rock-bottom for the second time. Trapped between the authorities and the company he helped build, he risks everything to give meaning to his second chance at life and his only chance for love.

"Genetic Imperfections" is a story of tragedy, greed, redemption and love, uniquely packaged in the thriller genre. It is available through Amazon, Kindle, Barnes and Noble, Nook, Apple’s iBooks, Smashwords, Diesel and Kobo. Visit for a synopsis and additional information.

Keep an eye out for Hadden’s next book, "Swimming Monkeys", set to be released later in the summer. A cross between Jurassic Park and The Da Vinci Code, Swimming Monkeys is a powerful coming-of-age thriller that examines the on-going struggle between science and religion.

About Steve Hadden
Steve Hadden is the author of "The Sunset Conspiracy", "Genetic Imperfections" and The "Swimming Monkeys" Trilogy. Steve was born in Ohio and has lived across the U.S. including stops in Maryland, Indiana, Pennsylvania, Oklahoma, Wyoming, California, Texas, Connecticut and Colorado. He’s traveled around the world and uses his experience and curiosity about the larger issues we face to bring his thrillers to life. Steve lives in Texas with his wife, CJ, and two Labrador retrievers, Emma and Abby. Visit his website at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Prosperous Agriculture Reports Outstanding Sales Result for First Half of 2012
2. Nourish the World! Terra Biotech Receives Thanks and Praise After First Shipment of 10,000 Servings of Nectr Core Vitamin Powder to Orphans in Ghana, Africa
3. Beyond Batten Disease Foundation and American Brain Foundation Launch First Clinical Research Fellowship to Treat and Cure Juvenile Batten Disease
4. NDIA, NTSA Will Be On Hand At Seventh Annual Capitol Hill Modeling and Simulation Expo, Set To Focus On Homeland Security, First Response
5. Pacific BioStorage Announces an Exciting New First for The Life Sciences Industry in Southern California
6. ScaleMatrix Leads the Way Unveiling the Industry’s First Transparent Pricing Tool in Private Cloud Offerings
7. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
8. CU-Boulder physicists use ultrafast lasers to create first tabletop X-ray device
9. First experiment at the ALBA synchrotron
10. EPSRC announces first recipients of Fellowships in Manufacturing
11. GeneLink Reports First Quarter 2012 Financial Results
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... 24, 2015  Clintrax Global, Inc., a worldwide provider of clinical ... today announced that the company has set a new quarterly earnings ... on quarter growth posted for Q3 of 2014 to Q3 of ... Mexico , with the establishment of an ... --> United Kingdom and Mexico ...
(Date:11/24/2015)... ... ... This fall, global software solutions leader SAP and AdVenture Capital brought together ... their BIG ideas to improve health and wellness in their schools. , Now, the ... title of SAP's Teen Innovator, an all-expenses paid trip to Super Bowl 50, and ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):